TY - JOUR T1 - Methylation-associated Silencing of microRNA-126 and its Host Gene <em>EGFL7</em> in Malignant Pleural Mesothelioma JF - Anticancer Research JO - Anticancer Res SP - 6223 LP - 6229 VL - 35 IS - 11 AU - MORTEN ANDERSEN AU - DAVIDE TRAPANI AU - JESPER RAVN AU - JENS BENN SØRENSEN AU - CLAUS BØGELUND ANDERSEN AU - MORTEN GRAUSLUND AU - ERIC SANTONI-RUGIU Y1 - 2015/11/01 UR - http://ar.iiarjournals.org/content/35/11/6223.abstract N2 - Background/Aim: We recently reported that miR-126 is down-regulated in malignant pleural mesothelioma (MPM) and can be combined into a 4-microRNA-classifier that can accurately diagnose MPM with high sensitivity and specificity. Herein we analyzed the epigenetic regulation of miR-126 and its host gene EGF-like domain, multiple 7 (EGFL7). Materials and Methods: Resected formalin-fixed paraffin-embedded MPM tissues from 29 patients, 14 patient-matched non-neoplastic pleura (NNP) specimens, 5 MPM diagnostic biopsies (DB), and 5 samples of pneumothorax-induced benign reactive mesothelial proliferation (PTHX) were analyzed. miR-126 and EGFL7 mRNA were quantified by RT-qPCR. CpG-islands' methylation in the EGFL7 promoter was analyzed using methylation-specific PCR and in the MIR126-containing intron 7 was quantified by pyrosequencing. Results: Relative to NNP, EGFL7 was under-expressed more than 4-fold in MPM (p&lt;0.001). EGFL7 mRNA and miR-126 levels correlated in MPM (p&lt;0.01) and NNP (p&lt;0.001). The EGFL7 promoter region was hypermethylated in 69% of MPM and 80% of DB samples, but not in NNP and PTHX samples. EGFL7 promoter hypermethylation was associated with epithelioid histology (p&lt;0.05) and reduced patient-survival (p&lt;0.05). Conclusion: In MPM, DNA-hypermethylation down-regulates miR-126 and its host gene EGFL7, therefore is a poor prognostic factor, and may represent a future therapeutic target for de-methylating strategies re-establishing EGFL7 and miR-126 expression. ER -